Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Jean N. DaSilva"'
Autor:
Elise P. Legault, Paula A. B. Ribeiro, Daniil R. Petrenyov, Gergana O. Drumeva, Charles Leduc, Sharmila Khullar, Jean N. DaSilva, Alain Steve Comtois, François B. Tournoux
Publikováno v:
BMC Sports Science, Medicine and Rehabilitation, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background It is unknown whether high-intensity interval exercise (HIIE) may potentiate or attenuate the cardiotoxic effect of chemotherapy agents such as doxorubicin (DOX) when performed shortly after treatment. The study aimed to investiga
Externí odkaz:
https://doaj.org/article/aafa0069412d461c8e6133fd283a249c
Autor:
Luis Michel Alonso Martinez, Nabil Naim, Alejandro Hernandez Saiz, José-Mathieu Simard, Mehdi Boudjemeline, Daniel Juneau, Jean N. DaSilva
Publikováno v:
Molecules, Vol 28, Iss 11, p 4517 (2023)
[13N]Ammonia is one of the most commonly used Positron Emission Tomography (PET) radiotracers in humans to assess myocardial perfusion and measure myocardial blood flow. Here, we report a reliable semi-automated process to manufacture large quantitie
Externí odkaz:
https://doaj.org/article/63c82189655c4016a3af69abedc71b8b
Autor:
Silvio Aime, Mohammed Al-Qahtani, Martin Behe, Guy Bormans, Giuseppe Carlucci, Jean N. DaSilva, Clemens Decristoforo, Adriano Duatti, Philip H. Elsinga, Klaus Kopka, Xiang-Guo Li, Zhibo Liu, Robert H. Mach, Oskar Middel, Jan Passchier, Marianne Patt, Ivan Penuelas, Ana Rey, Peter J. H. Scott, Sergio Todde, Jun Toyohara, Danielle Vugts, Zhi Yang
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-19 (2021)
Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results This commentary of highlights has resul
Externí odkaz:
https://doaj.org/article/dedd32d3753a4f61a5d5a18fc542f694
Autor:
Aida M. Abreu Diaz, Gergana O. Drumeva, Daniil R. Petrenyov, Jean-François Carrier, Jean N. DaSilva
Publikováno v:
ACS Omega, Vol 5, Iss 32, Pp 20353-20362 (2020)
Externí odkaz:
https://doaj.org/article/8b6e2bc6a2e947be9124899563ef21ba
Autor:
Mark H. Dornan, Daniil Petrenyov, José-Mathieu Simard, Mehdi Boudjemeline, Roxana Mititelu, Jean N. DaSilva, Anthony P. Belanger
Publikováno v:
ACS Omega, Vol 5, Iss 33, Pp 20960-20966 (2020)
Externí odkaz:
https://doaj.org/article/b15d2552aa214be09a19d0c4ba841fc7
Autor:
Mark H. Dornan, Daniil Petrenyov, José-Mathieu Simard, Antonio Aliaga, Guoming Xiong, Julien Ghislain, Barry Bedell, Vincent Poitout, Jean N. DaSilva
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 3, Iss 1, Pp 1-15 (2018)
Abstract Background The free-fatty acid receptor-1 (FFA-1) is expressed by β-cells and is a promising target for molecular imaging of functional β-cell mass. Recently, the ((3-[18F]fluoropropyl)sulfonyl)propoxy-derivative of the high-affinity FFA-1
Externí odkaz:
https://doaj.org/article/c7921ef1b9984e53b76aa893df52a43c
Autor:
Yan Zhang, Jean N. Dasilva, Tayebeh Hadizad, Stephanie Thorn, Drew Kuraitis, Jennifer M. Renaud, Ali Ahmadi, Myra Kordos, Robert A. Dekemp, Rob S. Beanlands, Erik J. Suuronen, Marc Ruel
Publikováno v:
Cell Transplantation, Vol 21 (2012)
Cell therapy is expected to restore perfusion and improve function in the ischemic/infarcted myocardium; however, the biological mechanisms and local effects of transplanted cells remain unclear. To assess cell fate in vivo, hexadecyl-4-[ 18 F]fluoro
Externí odkaz:
https://doaj.org/article/12fbb57fabe54e87b4cb2e0658802fc5
Autor:
Aida Mary Abreu Diaz, Zalua Rodriguez Riera, Yanick Lee, Luis Miguel Esteves, Charles‐Olivier Normandeau, Baptiste Fezas, Alejandro Hernandez Saiz, François Tournoux, Daniel Juneau, Jean N. DaSilva
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 66:73-85
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1396d2f8ebde2643e1cb9b65df0a5090
https://doi.org/10.1002/jlcr.4014
https://doi.org/10.1002/jlcr.4014
Autor:
Gergana O. Drumeva, Philippe Laporte, Luis Michel Alonso Martinez, Jean-François Carrier, Aida M. Abreu Diaz, Daniil R. Petrenyov, Jean N. DaSilva
Publikováno v:
Nuclear Medicine and Biology. :41-49
Introduction Alterations in the expression of the Angiotensin II type 1 receptors (AT1R) have been demonstrated in the development of several heart and renal diseases. The aim of this study was to evaluate the novel compound [18F]fluoropyridine-cande
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8293573a45b40c1bd918a8e63564d37c
https://doi.org/10.1016/j.nucmedbio.2021.03.003
https://doi.org/10.1016/j.nucmedbio.2021.03.003
Autor:
Gergana O. Drumeva, Jean N. DaSilva, Jean-François Carrier, Daniil R. Petrenyov, Aida M. Abreu Diaz
Publikováno v:
ACS Omega, Vol 5, Iss 32, Pp 20353-20362 (2020)
ACS Omega
ACS Omega
A novel 7-((4-(3-((2-[18F]fluoropyridin-3-yl)oxy)propyl)-1H-1,2,3-triazol-1-yl)methyl)-1H-benzo[d]imidazole derivative of the angiotensin II type-1 receptor (AT1R) blocker candesartan, [18F]fluoropyridine–candesartan, was synthesized via the copper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a4fa5816b2b62b43686c86657fb318d
https://doaj.org/article/8b6e2bc6a2e947be9124899563ef21ba
https://doaj.org/article/8b6e2bc6a2e947be9124899563ef21ba